Stocks Comparison
Entrepreneur Universe Bright vs Pharma-Bio Serv: revenue, profit, margins and growth compared
Entrepreneur Universe Bright brought in $5.7M of revenue in fiscal 2025, Pharma-Bio Serv $9M in fiscal 2025. Revenue changed by +7.7% at Entrepreneur Universe Bright and -5.3% at Pharma-Bio Serv on the year before, so Entrepreneur Universe Bright grew faster. Entrepreneur Universe Bright kept 33.5% of its revenue as net profit, Pharma-Bio Serv -1.1%. Free cash flow was $2.4M at Entrepreneur Universe Bright and -$221.5K at Pharma-Bio Serv.
Side by side, latest fiscal year
| EUBG | PBSV | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (October 31, 2025) |
| Revenue | $5.7M | $9M |
| Revenue growth | +7.7% | -5.3% |
| Net income | $1.9M | -$100.5K |
| Net margin | 33.5% | -1.1% |
| Free cash flow | $2.4M | -$221.5K |
| Free cash flow margin | 42.3% | -2.5% |
| Earnings per share (diluted) | $0.01 | -$0.00 |
| Cash | $11M | $3.4M |
| Debt | n/a | n/a |
| Price to earnings | 33.0 | n/a |
| Market value | $56.1M | $8M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #516 of 587 · Industrials | #508 of 587 · Industrials |
Over the years
Questions about Entrepreneur Universe Bright and Pharma-Bio Serv
Which is bigger by revenue, Entrepreneur Universe Bright or Pharma-Bio Serv?
Pharma-Bio Serv is bigger by revenue: $9M in fiscal 2025, against $5.7M for Entrepreneur Universe Bright in fiscal 2025.
Which keeps more of its revenue as profit, Entrepreneur Universe Bright or Pharma-Bio Serv?
Entrepreneur Universe Bright had a net margin of 33.5% in fiscal 2025; Pharma-Bio Serv had -1.1% in fiscal 2025.
Which grew revenue faster, Entrepreneur Universe Bright or Pharma-Bio Serv?
In their latest fiscal years revenue changed by +7.7% at Entrepreneur Universe Bright and -5.3% at Pharma-Bio Serv.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.